Press Releases

USAgainstAlzheimer’s Applauds Senators Susan Collins & Amy Klobuchar on Commitment to Increase Funding for Alzheimer’s Research

Senators introduce resolution to double Alzheimer’s research funding in FY2015, hit $2B by FY2019

USAgainstAlzheimer’s Applauds Announcement of Senator Edward Markey as Co-Chair of the Senate Alzheimer’s Task Force

Sen. Markey will bring proven leadership on Alzheimer’s to Task Force

2013 Geoffrey Beene Global NeuroDiscovery Challenge

Crowdvoting by Scientists and Public Determines

Round Two Winners of $50,000 21 CBT Innovation

Enrico Glaab, Ph.D., focuses on male-specific gene to unlock sex-based differences in the diagnosis and treatment of Alzheimer’s disease 

‘Path to 2025’ Alzheimer’s Disease Summit: Reforms Urgently Needed to Streamline Road to Alzheimer’s Prevention and Treatment as Global Prevalence is Set to Triple

New Report Provides Specific Recommendations for Governments, Academia, and Industry to Reduce Costs and Increase Efficiency in Alzheimer’s R&D so New Drugs Reach Patients Faster and Health Systems Save Billions

Dr. Peter L. Levin, Blue Button Healthcare Innovator, Joins USAgainstAlzheimer's Network

USAgainstAlzheimer’s Network Strengthens Innovation Capacity in Race to Stop Alzheimer’s by 2025

WASHINGTON, D.C. – The USAgainstAlzheimer's Network today announced that Dr. Peter L. Levin, developer of Blue Button personal health record technology during his role as Chief Technology Officer for the U.S. Department of Veteran Affairs, will join the USAgainstAlzheimer’s Network’s Board.


^ Back to Top